Marine Transcriptomic
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (15 August 2021) | Viewed by 6765
Special Issue Editor
Interests: transcriptomics; peptidomic; proteomics; immunity; neuropeptides; antimicrobial peptides
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Advances in bioinformatics and the increasing availability of sequenced genomes and transcriptomes provide more opportunities than ever in the discovery of novel bioactive compounds and biocatalysts from marine organisms.
In silico analysis of genomic or transcriptomic data is easier and more efficient today thanks to the development of new bioinformatics tools allowing access to multiple pieces of information and functionalities.
RNA-Sequencing allows detecting both known and novel features, to access differential expressions, gene networks, functions likely to reveal new molecules of interest.
For example, many microorganisms have the potential to produce a far greater number of natural products than have been isolated to date, since most biosynthetic gene clusters are either silent or expressed at very low levels when they are cultured under standard laboratory conditions.
On the other hand, in silico analysis of transcriptomes from other marine organisms such as venomous animals or organisms from extreme environments provides a considerable opportunity to identify new molecules with global health potential.
The identification of biosynthetic gene and gene clusters through a bioinformatics approach and their synthesis by eventual heterologous expression, will give a great impulse for natural products identification and drug discovery from marine organisms.
Dr. Céline Zatylny-Gaudin
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- marine organisms
- bioinformatics
- biosynthetic gene
- transcriptomes
- gene clusters
- heterologous expression
- drug discovery
- in silico analysis
